Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. - Wikidata - wikimedia - TriplyDB

Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.

Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.

http://www.wikidata.org/entity/Q38106748

about

Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene Prescribing menopausal hormone therapy: an evidence-based approach Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy.Critical appraisal of paroxetine for the treatment of vasomotor symptoms HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT Individually modifiable risk factors to ameliorate cognitive aging: a systematic review and meta-analysis Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women.Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes Conjugated estrogens for the treatment of menopausal symptoms: a review of safety data.A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy The effect and safety of postmenopausal hormone therapy and selective estrogen receptor modulators on kidney outcomes in women: a protocol for systematic review and meta-analysis.Advances in pharmacotherapy for treating female sexual dysfunction.Pharmacokinetics of the first combination 17β-estradiol/progesterone capsule in clinical development for menopausal hormone therapy Prevention of cognitive impairment in the midlife women Three midlife strategies to prevent cognitive impairment due to Alzheimer's disease.Melatonin and female hormone secretion in postmenopausal overweight women Conjugated Estrogens/Bazedoxifene (Duavee): A Novel Agent for the Treatment of Moderate-to-Severe Vasomotor Symptoms Associated With Menopause And the Prevention of Postmenopausal Osteoporosis.Menopausal Hormone Therapy, can we safely use it in women with co-morbidities?Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies.Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause.Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence.Guidelines for menopausal hormone therapy: Recommendations of the Polish Menopause and Andropause Society - state of knowledge as of December 2013.Hormone replacement therapy and the prevention of postmenopausal osteoporosis.Progestogen safety and tolerance in hormonal replacement therapy.Fractional CO2 laser therapy: a new challenge for vulvovaginal atrophy in postmenopausal women.Treatment of menopausal symptoms with three low-dose continuous sequential 17β-estradiol/progesterone parenteral monthly formulations using novel non-polymeric microsphere technology.Pharmacokinetic studies of solubilized estradiol given vaginally in a novel softgel capsule.A randomized, double-blind, placebo-controlled phase 2 pilot trial evaluating a novel, vaginal softgel capsule containing solubilized estradiol Behaviours and attitudes influencing treatment decisions for menopausal symptoms in five European countries Efficacy and safety of drospirenone 2 mg/17β-estradiol 1 mg hormone therapy in Korean postmenopausal women.The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophy.Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause.Prevention of diseases after menopause.Fertility desires, choice of hormone replacement and the effect of length of time since menopause on bone density in women with premature ovarian insufficiency: a review of 223 consecutive new referrals to a tertiary centre.A practitioner's toolkit for managing the menopause.Hormones and venous thromboembolism among postmenopausal women.Ultra-low dose - new approaches in menopausal hormone therapy.Premature ovarian failure with 46,XX,t(1;4)(p34.1;q34): first case report and literature review.Management of menopause in women with breast cancer.Environmental (nongenetic) factors in gynecological cancers: update and future perspectives.

P2860

Q26751149-EDFEBABA-79A0-4F48-A953-B9C8064A1275 Q27022920-ED8920CB-A74F-4AE8-B11E-38E44CBE6584 Q28081931-E1F872A6-CBEF-4CD5-8A6A-2A1185B1349B Q28084597-D3686203-5A2F-43B2-AA74-85A90DF7C45C Q28294446-65141219-9B16-4CD5-9B83-A982F9560073 Q28584559-F20D5F43-FCB9-49F2-945A-03436036E1BF Q30370912-079D8010-2697-4445-BF92-804FC38DFADF Q30409045-9887FA6E-00F1-4D33-8E36-DA3835031F99 Q30659580-19EA8699-CB91-4839-B5E9-0312B6BE2C43 Q33605919-15833FAB-EC6B-49F2-AC73-D7AD43E4219A Q33883362-0AF0E97C-DAAC-4F96-B3B7-658D6381B57D Q34465301-A7F763EE-5825-4FCF-9EED-4184655A40C4 Q34475143-343DF6F8-1A43-4F61-97BD-53EAEF87CAA7 Q34479407-CF133E72-5390-415C-992D-4AB730E4AB63 Q34536301-0E19CF0A-8B2D-4DB9-98D8-5B26AA84A45D Q35016542-C510260A-AD73-4BCC-9D35-8D4D5B011EA9 Q35170566-A90C01A2-380E-458F-B3CF-56E6134BEADB Q35313722-3CDAEE03-C574-40DB-902F-75C437423D50 Q35594488-FEAF32B1-D80A-488D-8C87-2608F03DA848 Q35647630-54B78830-875F-47CC-A377-538724F282CD Q35772337-939DA36A-C615-46B2-ABC9-2C60584CC444 Q35903489-05D39978-00C7-4145-8533-B85E4A88D78B Q35903603-CC110473-4DFF-496C-ABAB-053869275BD6 Q36109111-928FE5CE-8694-49B7-B716-A3B13DE82172 Q36371627-A39F581C-A33C-4173-9CAD-248271CD7B35 Q36647194-D68641A5-58A4-4FD8-A970-1613525AC62A Q36762596-D048A7E4-DC81-4D76-A236-3EC54881FB5C Q36846471-349A92B9-9EFC-4BE6-8EA9-E91E88E5D578 Q37248714-C5D7BF6E-ACC0-404F-A349-E3F220E93C1A Q37718913-9404DF5D-3AC5-4988-B628-6A4A0EDAD425 Q37722587-BA62E015-0897-4C1B-A307-0F04BB8B8F48 Q38178431-4EEF408A-A96D-4E56-A4DB-50FBD9800E76 Q38223587-603BB88C-99F0-427C-A588-E7DD862C27A8 Q38223975-F23F4DED-A54E-42AB-8076-0C304B85088B Q38226731-8C3B2C38-7EE2-4B68-BB36-A7E05A015639 Q38249888-F954C7F5-80DD-4B4C-8F00-62F1446CD267 Q38261770-4CE52987-8391-4EE1-A683-CCE9918D34CF Q38271744-2003A016-8861-4E35-9FB6-8CEC32702568 Q38298951-FAB91C6E-DA1A-44A4-BD0D-A57C46E92E05 Q38319580-F1536942-876C-4321-8A4A-12606C62037E

P2860

Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.

http://www.wikidata.org/entity/Q38106748

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Updated 2013 International Men ...... strategies for midlife health.

@en

type

label

Updated 2013 International Men ...... strategies for midlife health.

@en

prefLabel

Updated 2013 International Men ...... strategies for midlife health.

@en

P1433

Q38106748-E3DE9F21-B5E3-4E5F-9C50-CC53158C07FC

P1476

Q38106748-EFBE0561-7A4F-40C3-AE14-FF24B9DD1EF3

P2093

Q38106748-023AC494-15B0-44FB-AB44-59A8098F5E0E

Q38106748-0623346E-2143-48E0-A408-C839E32B4546

Q38106748-0A5F4B7A-E237-4AA3-9242-C1CFE67D6979

Q38106748-328CBBE8-984F-4873-9BB1-806657F778AE

Q38106748-3EC1B516-F782-4E6D-98A9-51AD263A6E95

Q38106748-5DFF96AF-6343-4E73-A2A2-B1F0DC1E08C6

Q38106748-65914194-54D9-4BC8-A3FD-30B4E1EAF05A

Q38106748-697A7BCF-53CF-435A-BF3D-74D9ADBB3113

Q38106748-744E8D96-FFAF-4F46-9742-7A2006B64FAE

Q38106748-A58A1016-2407-4F99-BB44-45DC42DEDB21

P2860

Q38106748-02C8BE20-25F5-4E1A-9F8D-5C35317F13D8

Q38106748-035C1F13-44FE-4AE0-A8DA-F1EC9064B9DD

Q38106748-03DD1577-3035-449F-B2C3-106BD6717192

Q38106748-07AED201-1514-4048-AFF0-27A8AF0E2C7C

Q38106748-0EEE4A4A-E584-4D0D-947C-577F185A3688

Q38106748-0EFCC1E4-0F8D-4473-AD26-75158DE88663

Q38106748-0F75CDDB-8C5A-4354-857C-A2F792ADEB29

Q38106748-15E58636-C730-4B17-B14A-CF928FAC3F91

Q38106748-186204EF-2AB5-44FF-A8A5-7DCCC83E9B3C

Q38106748-19236405-B832-4634-BD01-5C169A7B0193

P304

Q38106748-63C2FAF8-33CC-4757-877B-C032BA722B28

P31

Q38106748-4C5E6546-A56D-47BA-9C7F-8360A39C9E4D

P356

Q38106748-A3F92C2F-1313-464C-BA10-B10F16101179

P433

Q38106748-91E57756-2D18-4A3D-92F3-73AE2B72836A

P478

Q38106748-FA7EF957-4F64-4EA5-82D8-C8E846B15304

P50

Q38106748-6AFA3A32-E475-41D1-85FB-54961AB3ABE3

Q38106748-AB0280A4-EA7A-4A29-B887-B3756547F884

P577

Q38106748-6E13B87D-7A16-409C-BC89-31B3A5347BDF

P698

Q38106748-DDD9ECDA-EA75-415E-800C-AAC8A0517646

P356

13697137.2013.795683

P1433

P1476

Updated 2013 International Men ...... strategies for midlife health

@en

P2093

A A Gompel

http://www.w3.org/2001/XMLSchema#string

A Pines

http://www.w3.org/2001/XMLSchema#string

D F Archer

http://www.w3.org/2001/XMLSchema#string

D W Sturdee

http://www.w3.org/2001/XMLSchema#string

G Plu-Bureau

http://www.w3.org/2001/XMLSchema#string

International Menopause Society

http://www.w3.org/2001/XMLSchema#string

M Gambacciani

http://www.w3.org/2001/XMLSchema#string

N Panay

http://www.w3.org/2001/XMLSchema#string

R A Lobo

http://www.w3.org/2001/XMLSchema#string

R Langer

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis

Physical activity and risk of breast cancer among postmenopausal women

Bioidentical hormones for menopausal hormone therapy: variation on a theme

Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial.

P304

316-337

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/13697137.2013.795683

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23672656

http://www.w3.org/2001/XMLSchema#string